Invitris
Invitris is a protein-based drugs founded in 2022 by Patrick Grossmann.
2
Funding Rounds
$1.0m
Money raised
Overview
Invitris is a protein-based drugs founded in 2022 by Patrick Grossmann.
- Website:
- Headquarters: Munich
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ki**** Vo**** |
|
- | |
| Pa***** Gr******* |
|
- |
Funding series
Funding Series Analysis
The company Invitris has raised a total of $1m in funding over 2 rounds.
Key Insights:
- Invitris April 2023 Pre-Seed Funding Round: $500k
- Invitris April 2023 Pre-Seed Funding Round: $500k
Invitris April 2023 Pre-Seed Funding Round
$500k
Invitris April 2023 Pre-Seed Funding Round
$500k